|
|
Volumn 24, Issue 21, 2006, Pages
|
|
Myths and facts on adjuvant carboplatin for stage I seminoma.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
ADJUVANT CHEMOTHERAPY;
ADJUVANT THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
HUMAN;
MALE;
METASTASIS;
MULTICENTER STUDY;
NOTE;
ORCHIECTOMY;
PATHOLOGY;
RETROPERITONEAL TUMOR;
RISK ASSESSMENT;
SALVAGE THERAPY;
SECOND CANCER;
SEMINOMA;
TESTIS TUMOR;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
MALE;
MULTICENTER STUDIES;
NEOPLASM STAGING;
NEOPLASMS, SECOND PRIMARY;
ORCHIECTOMY;
RADIOTHERAPY, ADJUVANT;
RETROPERITONEAL NEOPLASMS;
RISK ASSESSMENT;
SALVAGE THERAPY;
SEMINOMA;
TESTICULAR NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 33746793746
PISSN: None
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2006.05.7802 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
